Impact of Opioid Free Anesthesia on Outcome After DIEPflap Surgery
DIEPflap
1 other identifier
observational
204
1 country
1
Brief Summary
The Deep Inferior Epigastric Perforator free flap (DIEPflap) involves the transfer of abdominal tissue to the breast using microsurgery. Flap failure is rare today, but is devastating. Blood flow in a DIEPflap decreases during the first hours. Many anesthetic factors like low cardiac output, hypothermia and surgical stress cause vasoconstriction or thrombosis. A stable anesthesia during these long procedures improves flap perfusion. Postoperative nausea and vomiting (PONV) is frequent and might have an impact. Opioid free anesthesia (OFA) reduces PONV. The anti-inflammatory and vasodilator effects of the drugs dexmedetomidine and lidocaine might improve free flap perfusion. The primary outcome counted all complications. The secondary outcomes were PONV, pain, opioid consumption, skin flap temperature and length of hospital stay. Patients get according to attending anesthesiologist an opioid or opioid free anesthesia without any randomization but based on availability of competence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 26, 2017
CompletedFirst Posted
Study publicly available on registry
June 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2019
CompletedResults Posted
Study results publicly available
February 23, 2021
CompletedFebruary 23, 2021
February 1, 2021
5.9 years
June 26, 2017
December 10, 2019
February 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Patients With One or More Complications
number of minor and major complications (CLAVIEN) (DINDOO)
One month postoperative
Secondary Outcomes (5)
Number of Patients With Post Operative Nausea or Vomiting
24 hours postoperative
Postoperative Pain: Visual Analog Scale
24 hours postoperative
Morphine Used
24 hours postoperative
Skin Temperature
24 hours post operative
Length of Hospital Stay
up to two weeks
Study Arms (2)
opioid free anesthesia (OFA)
The method of reaching OFA: Dexmedetomidine was given in a first loading dose 15 minutes before induction, a second loading dose at induction followed by an infusion for maintenance. Lidocaine is given as a loading dose at induction followed by infusion for maintenance. A Ketamine loading dose is given at induction with an extra bolus before incision followed by an infusion.
opioid anesthesia (OA)
OA was induced with sufentanil and continued with extra boli or a continuous infusion of remifentanil.
Interventions
general anesthesia blocking reflexes without using an opioid
Eligibility Criteria
woman who are admitted for breast reconstruction using the diepflap (free flap)
You may not qualify if:
- allergy to any of the drugs used in anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AZ Sint-Jan AVlead
Study Sites (1)
Azsintjan
Bruges, 8000, Belgium
Results Point of Contact
- Title
- Jan Mulier
- Organization
- AZSintJanAV
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Paul Mulier
AZSint Jan AV
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- chairman dep anesthesiology & Reanimation
Study Record Dates
First Submitted
June 26, 2017
First Posted
June 28, 2017
Study Start
January 1, 2014
Primary Completion
November 15, 2019
Study Completion
November 15, 2019
Last Updated
February 23, 2021
Results First Posted
February 23, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share